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There are several lines of evidence pointing towards the importance of b-oxidation in host survival of
Mycobacterium tuberculosis including enormous gene redundancy for this process; approximately 100
genes are annotated as b-oxidation genes for the ﬁve biochemical reactions that break down fatty acids
into acetyl-CoA. Although most of these genes are predicted to be non-essential, two of the genes (echA5
and fadB3) are annotated as essential for growth in vitro, and therefore could be considered as putative
drug targets. However, here we report the construction of echA5 and fadB3 null mutants conﬁrming they
are non-essential. No signiﬁcant difference in growth between the mutant and parent strains was
observed in either standard Middlebrook medium or in minimal medium supplemented with various
carbon sources. Macrophage survival and mouse infection studies also showed no signiﬁcant difference
between the mutant and parent strains. Therefore, we conclude that these genes are dispensable for
growth in vitro and in vivo.
 2011 Elsevier Ltd. Open access under CC BY license.1. Introduction
Tuberculosis (TB) is the leading cause of death from an infec-
tious disease worldwide and, although still primarily a disease of
developing countries, increased incidence of drug-resistant strains,
increased immigration and the worldwide HIV epidemic has
caused a gradual increase in the number of TB cases in developed
countries.1 More alarming is the rise in the global incidence of
multiple drug-resistant strains of Mycobacterium tuberculosis
(MDR-TB), the causative agent of TB. In some parts of theworld, one
in four people with tuberculosis becomes ill with a form of the
disease that can no longer be treated with standard drugs.2 Treat-
ment of such people relies on the use of less potent, more expensive
second line agents which require longer treatment times (up to two
years or more) and possess unpleasant side effects. There are also
reports of totally drug-resistant (TDR) TB strains emerging.3
Therefore, there is an urgent need for new and improved TB
drugs that are active against drug-resistant strains with novel
modes of action. This requires a concerted effort of drug targetx: þ44 207 594 3095.
obertson).
nse.identiﬁcation, thorough in vivo validation of drug targets and the
identiﬁcation of novel inhibitors.
The success ofM. tuberculosis as a pathogen lies in the ability of
the bacilli to replicate and persist in discrete microenvironments
within a mammalian host for long periods. In order to do so, the
bacilli must acquire and metabolise nutrients from surrounding
host tissue. Identiﬁcation of genes that are essential for intracellular
survival could therefore ultimately lead to the development of new
TB drugs that shorten treatment regimens. Growth on fatty acids as
sole carbon source requires the b-oxidation pathway and gluco-
neogenesis via the glyoxylate shunt. There is much evidence to
suggest that these fatty acid utilisation pathways play an important
role in host survival of mycobacteria such as the extensive lipid
degradation gene duplication (w100 genes annotated as b-oxida-
tion genes for the 5 reactions).4 Further evidence includes the
observation that fatty acids were shown to be the preferred carbon
source for mycobacteria isolated from animal lungs,5 deletion ofM.
tuberculosis isocitrate lyase 1 and 2 genes (key enzymes of the
glyoxylate cycle) caused severe growth inhibition ofM. tuberculosis
in mice,6 the up-regulation of fatty acid metabolism pathway genes
in nutrient starvation models and in macrophage and mice infec-
tion studies7,8 and the presence of lipid bodies in M. tuberculosis
isolated from TB patient sputum.9
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tion to produce acetyl-CoA, which feeds into the tricarboxylic acid
(TCA) cycle, and a fatty acid that is two carbons shorter in length
which is successively metabolized by this pathway (Figure 1).10 The
M. tuberculosis genome contains over 100 genes annotated as
enzymes involved in the ﬁve enzymatic reactions of b-oxidation,
whereas E. coli only has one enzyme set for each of the b-oxidation
pathway reactions under either anaerobic or aerobic conditions.10 It
has been postulated that the gene redundancy observed in
M. tuberculosis allows the bacilli to adapt and survive by switching
their metabolism to utilise the available carbon sources encoun-
tered in the various environments in vivo. However, this has not
been investigated. Although the majority of b-oxidation genes are
annotated as non-essential in vitro, possibly due to extensive gene
redundancy, two have been annotated as essential for in vitro
growth (Figure 1) based on saturating transposon mutagenesis
studies11,12 arguing against complete redundancy of these two
enzymatic steps.
Enoyl-CoA hydratase [EC 4.2.1.17] catalyses the third step in the
b-oxidation pathway, and echA5 is the only enoyl-CoA hydratase
out of 21 encoded in the M. tuberculosis genome thought to be
essential in vitro. The enzyme facilitates the addition of a water
molecule to an enoyl-CoA thioester, resulting in the formation of
a b-hydroxyacyl-CoA thioester (Figure 1). Studies have shown some
of the M. tuberculosis echA genes to have altered expression in
different environments. For example, in nutrient starvation models
echA8, echA11 and echA12 were shown to be up-regulated whereas
echA10 and echA21 were down-regulated.13,14 In macrophage
infection studies echA19was up-regulated7 whereas echA7was up-
regulated in mouse infections15 suggesting different roles for at
least some of the echA paralogues. However, to date there are no
reports on the role of echA5 or the altered expression of echA5 in
stress conditions or models of infection in the literature.
The enzyme encoded by fadB3, encoding a b-hydroxyacyl-CoA
dehydrogenase [EC 1.1.1.35], catalyses the fourth step of theFigure 1. The M. tuberculosis b-oxidation genes/pathway. Through successive rounds of oxid
glyoxylate shunt, into the TCA cycle. The echA5 and fadB3 genes are indicated.b-oxidation pathway, and is the only hydroxyacyl-CoA dehydro-
genase enzyme out of the ﬁve encoded in the M. tuberculosis
genome thought to be essential in vitro.11,12 Studies have shown the
M. tuberculosis fadB2 and fadB3 genes to be up-regulated in
macrophage infections and fadB2 up-regulated in mouse infection
studies.7,15 The fadB2 genewas also up-regulated in low pH and SDS
shock,16,17 and in the nutrient starvationmodel fadB and fadB4were
up-regulated.13,14 Furthermore, fadB5 was found to be deleted
(partially or completely) in one or more clinical isolates,18 although
the signiﬁcance of this is unclear. This also suggests different roles
for the ﬁve fadB paralogues in vivo.
In order to investigate the proposed in vitro essentiality of echA5
and fadB3 and to explore their roles further, null mutant
construction were attempted. Rather unexpectedly, null mutants
for both genes in M. tuberculosis could be obtained. Therefore, we
probed the function of these genes further by in vitro growth
analysis of the parent and mutant strains on various sole carbon
sources. Additionally, the ability of the mutant strains to infect and
survive within bone-marrow derived mouse macrophages and to
cause infection within the mouse model was investigated.
2. Materials and methods
2.1. Bacterial strains and growth conditions
M. tuberculosis H37Rv was grown in Middlebrook 7H9-Tw-
Glycerol-OADC liquid broth (supplemented with 0.2% glycerol,
0.05% Tween-80 and 10% OADC) at 37 C shaken at 150 r.p.m. in an
orbital shaker, on Middlebrook 7H11 solid media supplemented
with 0.5% glycerol and 10% OADC (Becton Dickinson) or in Sauton’s
Minimal Medium supplemented with 0.2% glycerol, 0.0001% ZnSO4
and 0.025% Tyloxapol as described previously.19 For growth with
various carbon sources, Sauton’s minimal medium (without glyc-
erol) was supplemented with the ﬁnal concentration of carbon
source as follows: 0.2% glucose, 10 mM sodium butyrate, 1 mMation, fatty acids are broken down to produce acetyl-coA which is assimilated, via the
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10 mM sodium pyruvate, 0.1 mM sodium stearate, 0.1 mM iso-
palmitate, 0.1 mM palmitate, 0.1 mM Dipalmitoyl-phosphatidyl-
choline (DPC) and 0.1 mMMethyl-arachidonate (MA). All fatty acid
sodium salts were prepared by dissolving the powder in water
except for palmitate, isopalmitate, stearate, cholesterol, DPC and
MA which were dissolved in a 1:1 Tyloxapol:Ethanol mix at 80 C
heat as described previously.20 All E. coli strains were grown on LB-
agar plates or in LB broth. Hygromycin (Invitrogen) was added as
required at a concentration of 200 mgml1 for E. coli and 50 mgml1
for mycobacteria. Kanamycin (Sigma) was added at a concentration
of 50 mg ml1.
2.2. Plasmids and DNA work
Plasmids were generated by using standard cloning procedures.
The correct sequence of all cloned PCR fragments was conﬁrmed by
DNA sequencing. Genomic DNA was prepared as described previ-
ously.21 PCR was performed using Qiagen High Fidelity Taq poly-
merase according to manufacturer’s instructions with the addition
of 5% DMSO.
2.3. Construction of echA5 and fadB3 null mutants
The mycobacteriophage-based method of specialized trans-
duction, which utilizes conditionally replicating shuttle phasmids
created from pHAE159 and pYUB854, was used to create the
M. tuberculosis mutants. Initially, upstream (UP) and downstream
(DN) sequences ﬂanking the genes to be mutated were ampliﬁed
from M. tuberculosis genomic DNA by PCR as stated. Primer
sequences are listed inTable 1. Theﬂanking regionsweredesigned so
as not to disrupt any neighbouring predicted essential genes or to
introduce anydownstreameffects. The resultingknock-outplasmids
pDEKO (echA5) and pDFKO (fadB3) were then used in accordance
with the method by Bardarov et al.22 to generate the recombinant
phage for transduction into M. tuberculosis. Putative null mutants
were selected on 7H11 agar containing hygromycin (50 mg ml1).
2.4. Conﬁrmation of mutant construction
Conﬁrmation of gene deletion was carried out by PCR on gDNA
using primers outside the upstream and downstream ﬂanking
regions in combination with hygromycin cassette speciﬁc primersTable 1





















fadB3_ko_screen_R 50-GATCTATCTGCTCAGCGACG(Table 1). PCR products would only be obtained with insertion of
the hygromycin cassette by recombination onto the chromosome at
the correct location. PCR over the disrupted region was also per-
formed. Further conﬁrmation was provided by Western analysis
using a custom made EchA5 peptide-speciﬁc polyclonal antibody
(Eurogentec, Belgium).2.5. Growth analysis of strains
M. tuberculosiswild type andmutant strains were grown tomid-
log phase (OD 0.8e1) in 7H9 media as previously stated. The cells
were then washed twice with PBS, resuspended in PBS and used to
inoculate fresh medium (7H9-Tw-Glycerol-OADC or Sauton’s
minimal medium plus required carbon source) to a starting OD600
of 0.05. Growth was analysed by taking OD600 readings. All analyses
were performed in triplicate except where stated.2.6. In vitro infection of bone-marrow derived murine macrophages
Macrophages were derived from mouse bone-marrow cells by
culture for 7 days in RPMI 1640 (Lonza) supplemented with 1 mM
sodium pyruvate (Lonza), 2 mM L-glutamine (Lonza), 0.05M
2-mercaptoethanol (Gibco), 10% heat-inactivated foetal bovine
serum (Biosera) and 20% L-cell conditioned media. Macrophages
were seeded into 24-well tissue culture plates at a concentration of
5  105 cells per well and allowed to adhere overnight.
M. tuberculosis strains were grown to mid-exponential phase, pel-
leted by centrifugation, washed twice with PBS-Tween, once with
PBS and resuspended in RPMI to a concentration of 5105 cfuml1.
The bacteria were added to the monolayers at a multiplicity of
infection (m.o.i.) of 1 for 4 h at 37 C in triplicate wells. The medium
was removed and replaced with RPMI medium containing
200 mg ml1 amikacin and incubated for 45 min at 37 C. The
monolayerswere thenwashed three timeswithRPMI to remove free
bacteria and then cultured inRPMI at 37 Cwith 5%CO2. Intracellular
survival and growth was assessed by lysis of the monolayers by the
addition of water followed by a 30 min incubation at room
temperature and enumeration of bacteria by serial dilution in PBS-
Tween plating onto Middlebrook 7H11 solid medium supple-
mented with 0.5% glycerol and 10% OADC. Colonies were counted
after 3e4 weeks incubation at 37 C and the average cfu/well
determined.Purpose
Directional cloning of echA5 upstream region into pYUB854
“
Directional cloning of echA5 downstream region into pYUB854
“
Directional cloning of fadB3 upstream region into pYUB854
“
Directional cloning of fadB3 downstream region into pYUB854
“
Conﬁrmation of fadB3 knock-out e upstream region
“
Conﬁrmation of fadB3 knock-out e downstream region
“
Conﬁrmation of echA5 knock-out e upstream region
“
Conﬁrmation of echA5 knock-out e downstream region
“
PCR over echA5 gene
“
PCR over fadB3 gene
“
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Eight-week-oldC57Bl/6micewere infectedwith100e140 colony
forming units ofM. tuberculosis H37Rv parental strain or the 2 gene
knock-out strains byaerosol using a BioAerosol nebulizing generator
(CH Technologies Inc., Westwood, NJ) for 10 min. Groups of 5 mice
for each strain were euthanized on days 1, 14, 28 and 56 and lungs
and spleens homogenized in Middlebrook 7H9-Tw-Glycerol-OADC
liquid broth. Appropriate dilutions were plated on Middlebrook
7H11 solidmedium supplementedwith 0.5% glycerol and 10% OADC
in duplicate and incubated at 37 C for colony enumeration.3. Results
3.1. Construction and conﬁrmation of echA5 and fadB3 M.
tuberculosis null mutants
The method of Bardarov et al.22 was used to attempt mutant
construction by allelic exchange in M. tuberculosis. Unexpectedly,
mutant strains for both genes could be obtained. Allelic exchange
was conﬁrmed by PCR using oligonucleotides speciﬁc to the
hygromycin cassette and to the genomic region outside of the
target-gene ﬂanking regions used to construct the mutants. PCR
products would only be obtained if the hygromycin cassette had
inserted into the correct location on the chromosome. PCR products
of the expected size were obtained for the null mutants; no prod-
ucts were obtained for the wild type parent strain or the plasmid
used to construct themutants (Figures 2 and 3). PCR over the region
of disruption further conﬁrmedmutant construction by showing an
increase in size corresponding to insertion of the hygromycin
cassette at this location (Figures 2 and 3). Additional conﬁrmation
that the echA5 gene has been disrupted was provided by WesternFigure 2. Conﬁrmation of echA5 null mutant genotype by PCR. PCR products of the expected
using pYB_Out2 and mmpL5_F oligos (PCR2); no products were obtained with wild type or
oligos further conﬁrms the correct insertion of the hygromycin cassette (PCR3).blot showing the absence of the corresponding 27.5 kDa protein in
the mutant strain compared to the wild type (Supplementary Data
Figure S1). Antibody was not available for FadB3 Western analysis.
3.2. Initial in vitro growth analysis of parent and mutant strains in
standard growth medium
The b-oxidation null mutant strains showed no growth defect
compared to wild type when grown in 7H9 medium (Figure 4a).
However, this medium contains many carbon sources and it was
therefore investigated whether any potential growth defect of the
mutant was being masked by the presence of other fatty acids and
carbon sources in the medium. For example, the Middlebrook 7H9-
Tw-Glycerol-OADC medium used for propagation of these strains
contains glycolytic carbon sources in the formof glycerol andglucose
aswell as theb-oxidation substrate oleic acid, including theoleic acid
released during hydrolysis of Tween-80. Therefore growth analysis
of the mutants in Sauton’s minimal medium where the surfactant
Tween-80 was replaced with the non-hydrolyzable surfactant
Tyloxapol with glycerol as the sole carbon source was performed
(Figure 4b). Sauton’s minimal medium with no exogenous carbon
source was included as a negative control in all growth studies. The
mutants grew at a slightly slower rate on glycerol compared to wild
type, but could still utilise glycerol as a sole carbon source and
therefore in terms of the essentiality of these genes for growth using
glycerol as a sole carbon source this was not deemed signiﬁcant.
3.3. Further in vitro growth analysis of parent and mutant strains in
various carbon sources
In order to investigate the role of these genes further, growth in
Sauton’s minimal medium supplemented with a variety of fattysize were obtained for the mutants with pYB_HygOut1 and echA4_F oligos (PCR1), and
knock-out plasmid DNA (PCRs 1 & 2). PCR over the echA5 gene using echA5_ko_screen
Figure 3. Conﬁrmation of fadB3 null mutant genotype by PCR. PCR products of the expected size were obtained for the mutants with pYB_HygOut1 and engA_F oligos (PCR1), and
using pYB_Out2 and Rv1718_R oligos (PCR2); no products were obtained with wild type or knock-out plasmid DNA (PCRs 1 & 2). PCR over the fadB3 gene using fadB3_ko_screen
oligos further conﬁrms the correct insertion of the hygromycin cassette (PCR3).
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propionate, butyrate, stearate, cholesterol, acetate, palmitate, iso-
palmitate, Dipalmitoyl-phosphatidylcholine (DPC), Methyl-
arachidonate (MA) and pyruvate; although the growth rate varied
between each carbon source, there was no signiﬁcant difference in
growth rate betweenwild type and mutant strains (Supplementary
Data Figure S2). As was observed with glycerol as the sole carbon
source, the mutants grew at a slower rate on glucose compared to
wild type, however in terms of the essentiality of the genes for
growth on glucose this was not deemed signiﬁcant.
3.4. Survival of parent and mutant strains in vivo
To test the importance of echA5 and fadB3 during intracellular
growth in host cells, we infected mouse bone-marrow-derived
macrophages with wild type, echA5 ko mutant and fadB3 ko
mutant strains at a multiplicity of infection (m.o.i.) of 1. All three
bacterial strains showed intracellular growth over the ﬁrst 2 days
post-infection and by day 4 post-infection a slight reduction in
intracellular growth had occurred, however no difference in growth
or survival between the parent and mutant strains was observed
(Figure 5). Similarly, there was no defect in growth or survival of
these strains in the lung or the spleens of infected mice up to 8
weeks post-infection (Figure 6).
4. Discussion
Metabolic adaption to the host niche is critical for the survival
and pathogenicity of M. tuberculosis. Although bacteria can utilise
a variety of carbon sources for growth in vitro, fatty acids are
thought to provide the major source of carbon for growth during
intracellular infection.4,7,8,10 The fatty acid(s) available as carbon
sources will vary depending on the host environment the bacilli
reside in and therefore it has been proposed that the enormous
gene redundancy observed in the M. tuberculosis genome for theenzymes involved in this process is to allow the bacilli to adapt and
metabolise the available carbon source either aerobically or
anaerobically. This hypothesis is further supported by the obser-
vation that the non-pathogenic enteric bacteria E. coli genome only
encodes one set of genes for either aerobic or anaerobic b-oxidation
of fatty acids.5,7,8
Themajority ofM. tuberculosis genes in the b-oxidation pathway
are annotated as non-essential in vitro.11 However, the exact role of
the annotated b-oxidation enzymes in fatty acid utilisation in vitro
and in vivo is not known. There is currently very limited
biochemical investigation into the precise role of most of the
enzymes in the b-oxidation pathway and therefore some genome
annotation mistakes cannot be completely ruled out. In this study,
we investigated the role of two b-oxidation genes thought to be
essential for growth in vitro because transposon mutants for these
two genes have not been reported in two independent mutagenesis
screens11,12 and are not available via target (http://webhost.nts.jhu.
edu/target/). However, null mutants could be obtained and there-
forewe conﬁrmed that these genes are in fact non-essential in vitro.
There are alternative explanations for the lack of genetic disruption
observed in a transposon screen other than essentiality. For
example, the transposon library may not be completely saturated,
the transposon may not be able to insert itself at a particular
genomic region due to secondary structure and the genetic location
of the gene may be signiﬁcant (if a gene is situated in an operon
upstream of essential genes then this gene will not be disrupted
although may not itself be essential). fadB3 is in an operon with
putative essential genes upstream but only non-essential genes
downstream. echA5 is the last gene of an operon with a putative
essential gene upstream, so it is unclear as to why a transposon
mutant was not obtained for these genes. This highlights the need
to conﬁrm essentiality predictions by targeted mutagenesis.
In order to explore the possibility that the paralogues play a role
in utilising different carbon sources, the growth of the mutant
strains in a variety of different fatty acids as sole carbon sources was
Figure 6. In vivo growth and survival of the parent and mutant strains. Growth was
monitored in the lungs (a) or the spleen (b) over 8 weeks post-infection. Results shown
are the median cfu/ml from groups of ﬁve mice. Error bars represent SD.
Figure 4. Growth kinetics of M. tuberculosis (H37Rv), echA5 mutant and fadB3 mutant
in (a) Middlebrook 7H9-Tw-Glycerol-OADC medium and (b) Sauton’s minimal medium
plus 0.2% glycerol. Results shown are the average of three independent experiments.
Error bars represent SD.
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starvation model induced 13 b-oxidation genes14 and it is therefore
thought that the bacilli switch to the b-oxidation of fatty acids to
drive the supply of central metabolites via the glyoxylate shunt and
gluconeogenesis. Therefore, a range of carbon chain length fatty
acids was chosen for testing in this study and cholesterol, thoughtFigure 5. The intracellular growth of the parent and mutant strains within mouse
bone-marrow derived macrophages. Results shown are the average of triplicate wells
and are representative of two independent experiments. Error bars represent SD.to be important in bacilli host infection and persistence,20,23 was
also studied. However, the mutants grew on all of the carbon
sources tested, suggesting that these genes are not solely respon-
sible for the metabolism of these carbon sources. Although gene
redundancy may be masking any mutant phenotype, we have not
fully recapitulated all the potential substrates the bacillus may
encounter in vivo in this study and a unique role of the echA5 and
fadB3 genes in the metabolism of other fatty acids cannot be
completely ruled out. Furthermore, null mutants in vitro undergo
many generations of growth during which compensatory muta-
tions and/or gene expression changes may occur to overcome the
loss of the gene in that environment.
M. tuberculosis displays a signiﬁcant transcriptional response
with more than 600 genes having altered expression levels upon
phagocytosis by a macrophage.7 In the phagosome, the bacilli are
presumably exposed to a limited availability of nutrients, yet they
can replicate and persist within the phagosome. Therefore, we
tested the ability of the mutant strains to grow and survive within
macrophages. Once again no difference was observed with growth
occurring for all strains up to 2 days post-infection with a slight
drop in survival by day 4. Although the lack of phenotype in the
mutant strains is perhaps not unsurprising given the enormous
gene redundancy, fadB3 has previously been shown to be up-
regulated in macrophage infections,7 however, we show in this
study that it is not required for intracellular survival. It is thought
that some central metabolism genes may be up-regulated as
a general stress response24 and this and/or the possible gene
redundancy (fadB2 is also up-regulated in macrophage infection7)
may account for lack of intracellular phenotype with the fadB3
mutant. There has been no reported altered echA5 gene expression
K.J. Williams et al. / Tuberculosis 91 (2011) 549e555 555in the macrophage model and we conﬁrm it is not individually
required for macrophage survival. Similarly for the mouse infection
studies, no difference was observed between the parent and
mutant strains for infection of the lungs or spleen up to 8 weeks
post-infection. In a genetic screen for genes required for growth
in vivo, neither echA5 nor fadB3 were predicted to be required for
survival in the mouse model.25 However, these mutants may not
have been included in the pool of mutants investigated as no
transposon mutant was obtained previously leading to the
assignment of these genes as essential for in vitro growth.11
However, eight fatty acid degradation genes were predicted to be
required for in vivo infection,25 further supporting the important
role of lipid degradation in the survival of M. tuberculosis in the
host. However, we observed that echA5 and fadB3 are not individ-
ually required for survival in vivo.
In summary, we show the b-oxidation genes echA5 and fadB3 are
non-essential for growth in vitro or in vivo and based on this study
we would not consider these genes as viable drug targets. There is
an urgent need for new TB treatment shortening drugs with novel
modes of action. Very few drug targets make it through to pre-
clinical studies as compounds active against the target in vitro
often have no activity in animal models. Therefore, druggable gene
products that are required for in vivo survival need to be identiﬁed.
However, this is not straightforward, since genes essential for
in vitro growth cannot be studied by conventional knock-out
genetics, but instead require more complex conditional expres-
sion systems for study. Although initially the b-oxidation pathway
genes echA5 and fadB3 looked like viable drug targets as they were
predicted to be essential in vitro and the pathway thought to be
important in vivo, they turned out not to be attractive drug targets.
Although the utilisation of fatty acids via the b-oxidation pathway
is still thought to be important for in vivo survival ofM. tuberculosis,
the enormous gene redundancymakes biochemical investigation of
this pathway difﬁcult. Therefore, the generation of double or
multiple gene knock-out strains may be required for further
investigations into this pathway’s role in the metabolism and
intracellular survival of M. tuberculosis.Acknowledgements
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